BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34330900)

  • 21. Misfolded amyloid-β-42 impairs the endosomal-lysosomal pathway.
    Marshall KE; Vadukul DM; Staras K; Serpell LC
    Cell Mol Life Sci; 2020 Dec; 77(23):5031-5043. PubMed ID: 32025743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
    J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes.
    Pacheco-Quinto J; Eckman EA
    J Biol Chem; 2013 Feb; 288(8):5606-15. PubMed ID: 23283972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization.
    Naito Y; Tanabe Y; Lee AK; Hamel E; Takahashi H
    Sci Rep; 2017 Feb; 7():42548. PubMed ID: 28211900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-β oligomers in cellular models of Alzheimer's disease.
    Fontana IC; Zimmer AR; Rocha AS; Gosmann G; Souza DO; Lourenco MV; Ferreira ST; Zimmer ER
    J Neurochem; 2020 Nov; 155(4):348-369. PubMed ID: 32320074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of α-Synuclein Fibrillar Strains and β-Amyloid Assemblies on Mouse Cortical Neurons Endo-Lysosomal Logistics.
    Chou QL; Alik A; Marquier F; Melki R; Treussart F; Simonneau M
    eNeuro; 2022; 9(3):. PubMed ID: 35470226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes.
    Pacheco-Quinto J; Clausen D; Pérez-González R; Peng H; Meszaros A; Eckman CB; Levy E; Eckman EA
    FASEB J; 2019 Mar; 33(3):3758-3771. PubMed ID: 30481490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Norambuena A; Wallrabe H; McMahon L; Silva A; Swanson E; Khan SS; Baerthlein D; Kodis E; Oddo S; Mandell JW; Bloom GS
    Alzheimers Dement; 2017 Feb; 13(2):152-167. PubMed ID: 27693185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
    Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
    ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel crosslinking protocol stabilizes amyloid β oligomers capable of inducing Alzheimer's-associated pathologies.
    Cline EN; Das A; Bicca MA; Mohammad SN; Schachner LF; Kamel JM; DiNunno N; Weng A; Paschall JD; Bu RL; Khan FM; Rollins MG; Ives AN; Shekhawat G; Nunes-Tavares N; de Mello FG; Compton PD; Kelleher NL; Klein WL
    J Neurochem; 2019 Mar; 148(6):822-836. PubMed ID: 30565253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers.
    Nunes-Tavares N; Santos LE; Stutz B; Brito-Moreira J; Klein WL; Ferreira ST; de Mello FG
    J Biol Chem; 2012 Jun; 287(23):19377-85. PubMed ID: 22505713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia.
    Zempel H; Mandelkow EM
    Mol Neurodegener; 2015 Dec; 10():68. PubMed ID: 26691836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.